MARKET

BETRF

BETRF

Betterlife Pharma Inc
OTCMQB
0.176
+0.016
+10.06%
Closed 15:16 07/30 EDT
OPEN
0.160
PREV CLOSE
0.160
HIGH
0.176
LOW
0.160
VOLUME
51.00K
TURNOVER
8.18K
52 WEEK HIGH
0.176
52 WEEK LOW
0.028
MARKET CAP
28.75M
P/E (TTM)
-19.3516
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BETRF last week (0720-0724)?
Weekly Report · 3d ago
Weekly Report: what happened at BETRF last week (0713-0717)?
Weekly Report · 07/20 10:27
BetterLife Pharma shifts lead drug BETR-001 development focus to migraine, headache disorders
PUBT · 07/13 18:40
BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism
Newsfile · 07/13 12:00
Weekly Report: what happened at BETRF last week (0706-0710)?
Weekly Report · 07/13 10:29
BetterLife Pharma appoints John W. LaRocca to board, audit committee
PUBT · 07/09 12:03
BetterLife Pharma partners with Nucro-Technics for final GLP tox study supporting BETR-001 IND filing
PUBT · 07/06 12:18
BetterLife Pharma signs deal with Nucro-Technics for final GLP tox study of BETR-001 ahead of IND filing
PUBT · 07/06 12:02
More
About BETRF
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical, is a non-hallucinogenic second-generation lysergic acid diethylamide (LSD) derivative molecule that mimics the projected therapeutic potential of LSD in the treatment of disorders, such as depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical, is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound, with the potential for treatment of anxiety related disorders, including benzodiazepine dependency. It is also refining and developing drug candidates from a set of complementary interferon-based technologies, which have the potential to engage the immune system to fight viral infections.

Webull offers BetterLife Pharma Inc stock information, including OTCMQB: BETRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BETRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BETRF stock methods without spending real money on the virtual paper trading platform.